London, UK, December 17th, 2018. LifeArc, a leading UK medical research charity, is delighted to launch a new Technology Transfer Fellowship programme in partn [...]
About Lucy TuffinThis author has not yet filled in any details.
So far Lucy Tuffin has created 47 blog entries.
Medical software developed at UCL that overlays tumour information from MRI scans onto ultrasound images can help guide surgeons conducting biopsies and improve [...]
The government has published the second Life Sciences Sector Deal, which outlines public and private sector investments into the sector. Investments into three [...]
A single infusion of FLT180a resulted in sustained mean Factor IX activity of 45%, with no toxicity or adverse effects, and eliminated need for patient infusion [...]
UCLTF has invested in a series A round for immuno-oncology company IGEM Therapeutics. The £5million funding round also included investment from Alsa Holdings an [...]
AI spinout Hazy, featured in a recent Forbes list selecting the 15 Machine Learning Companies to Watch in Europe. Hazy made the top 10, for its platform that al [...]
UCL Spin-out Engitix Closes £5m Financing to Progress Liver Disease & Pancreatic Cancer Drug Discovery Platform & PipelineLucy Tuffin2018-11-27T10:25:05+00:00
Engitix Ltd, a company pioneering the development of both tissue-specific and disease-specific human extracellular matrix (ECM) for accelerating and improving t [...]
SmartTarget Ltd, a spinout of UCL (University College London) that has developed a CE-approved device for precision prostate biopsy and focal therapy, is please [...]
Simon Goldman and David Grimm, who are responsible for managing investments for the UCL Technology Fund, the fund co-managed by UCLB and Albion Capital, have to [...]
UCL spinout Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, [...]